Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1579

1.

Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy.

Hochreiter A, Kelly JR, Young MR, Litkouhi B, Black JD, Stromberger C, Higgins S, Schwartz PE, Damast S.

Int J Gynecol Cancer. 2019 Nov 12. pii: ijgc-2019-000675. doi: 10.1136/ijgc-2019-000675. [Epub ahead of print]

PMID:
31722964
2.

Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy.

Zammataro L, Lopez S, Bellone S, Pettinella F, Bonazzoli E, Perrone E, Zhao S, Menderes G, Altwerger G, Han C, Zeybek B, Bianchi A, Manzano A, Manara P, Cocco E, Buza N, Hui P, Wong S, Ravaggi A, Bignotti E, Romani C, Todeschini P, Zanotti L, Odicino F, Pecorelli S, Donzelli C, Ardighieri L, Angioli R, Raspagliesi F, Scambia G, Choi J, Dong W, Bilguvar K, Alexandrov LB, Silasi DA, Huang GS, Ratner E, Azodi M, Schwartz PE, Pirazzoli V, Stiegler AL, Boggon TJ, Lifton RP, Schlessinger J, Santin AD.

Proc Natl Acad Sci U S A. 2019 Nov 5;116(45):22730-22736. doi: 10.1073/pnas.1911385116. Epub 2019 Oct 17.

PMID:
31624127
3.

Assessing the Potential Risk of Cross-Reactivity Between Anti-Bococizumab Antibodies and Other Anti-PCSK9 Monoclonal Antibodies.

Wang EQ, Bukowski JF, Yunis C, Shear CL, Ridker PM, Schwartz PF, Baltrukonis D.

BioDrugs. 2019 Oct;33(5):571-579. doi: 10.1007/s40259-019-00375-0.

4.

AAOMS Response to Recent Challenges to OMS Office-Based Anesthesia for Pediatric Patients.

Indresano AT, Nannini VL, Tiner BD, Johnson JD Jr, Ferguson BL, Shafer D, Schwartz PJ, Clark RS, Morrison JD, Crago CA, Egbert MA.

J Oral Maxillofac Surg. 2019 Sep 12. pii: S0278-2391(19)31071-7. doi: 10.1016/j.joms.2019.09.002. [Epub ahead of print] No abstract available.

PMID:
31525330
5.

Mothers with long QT syndrome are at increased risk for fetal death: Findings from a multicenter international study.

Cuneo BF, Kaizer AM, Ann Clur S, Swan H, Herberg U, Winbo A, Rydberg A, Haugaa K, Etheridge S, Ackerman MJ, Dagradi F, Killen SAS, Waker-Gussmann A, Benson DW, Wilde AAM, Pan Z, Lam A, Spazzolini C, Horigome H, Schwartz PJ; Fetal LQTS Consortium.

Am J Obstet Gynecol. 2019 Sep 11. pii: S0002-9378(19)31109-3. doi: 10.1016/j.ajog.2019.09.004. [Epub ahead of print]

PMID:
31520628
6.

Association Between Power Morcellation and Mortality in Women With Unexpected Uterine Cancer Undergoing Hysterectomy or Myomectomy.

Xu X, Lin H, Wright JD, Gross CP, Boscoe FP, Hutchison LM, Schwartz PE, Desai VB.

J Clin Oncol. 2019 Sep 16:JCO1900562. doi: 10.1200/JCO.19.00562. [Epub ahead of print]

PMID:
31518176
7.

Role of radiation therapy for retroperitoneal sarcomas: An eight-institution study from the US Sarcoma Collaborative.

Chouliaras K, Senehi R, Ethun CG, Poultsides G, Grignol V, Clarke CN, Roggin KK, Fields RC, Schwartz PB, Ronnekleiv-Kelly SM, D'Agostino R Jr, Johnson EN, Levine EA, Cardona K, Votanopoulos KI.

J Surg Oncol. 2019 Dec;120(7):1227-1234. doi: 10.1002/jso.25694. Epub 2019 Sep 4.

PMID:
31486096
8.

Towards Precision Medicine With Human iPSCs for Cardiac Channelopathies.

Wu JC, Garg P, Yoshida Y, Yamanaka S, Gepstein L, Hulot JS, Knollmann BC, Schwartz PJ.

Circ Res. 2019 Aug 30;125(6):653-658. doi: 10.1161/CIRCRESAHA.119.315209. Epub 2019 Aug 29.

PMID:
31465267
9.

Genetic Mosaicism in Calmodulinopathy.

Wren LM, Jiménez-Jáimez J, Al-Ghamdi S, Al-Aama JY, Bdeir A, Al-Hassnan ZN, Kuan JL, Foo RY, Potet F, Johnson CN, Aziz MC, Carvill GL, Kaski JP, Crotti L, Perin F, Monserrat L, Burridge PW, Schwartz PJ, Chazin WJ, Bhuiyan ZA, George AL Jr.

Circ Genom Precis Med. 2019 Sep;12(9):375-385. doi: 10.1161/CIRCGEN.119.002581. Epub 2019 Aug 27.

PMID:
31454269
10.

Editorial About: "A Prospective, Open-Label, Multicenter Phase II Trial of Neoadjuvant Therapy Using Full-Dose Gemcitabine and S-1 Concurrent with Radiation for Resectable Pancreatic Ductal Adenocarcinoma".

Schwartz PB, Uboha NV, Weber SM.

Ann Surg Oncol. 2019 Aug 22. doi: 10.1245/s10434-019-07737-6. [Epub ahead of print] No abstract available.

PMID:
31440923
11.

PARP-1 activity (PAR) determines the sensitivity of cervical cancer to olaparib.

Bianchi A, Lopez S, Altwerger G, Bellone S, Bonazzoli E, Zammataro L, Manzano A, Manara P, Perrone E, Zeybek B, Han C, Menderes G, Ratner E, Silasi DA, Huang GS, Azodi M, Newberg JY, Pavlick DC, Elvin J, Frampton GM, Schwartz PE, Santin AD.

Gynecol Oncol. 2019 Oct;155(1):144-150. doi: 10.1016/j.ygyno.2019.08.010. Epub 2019 Aug 18.

PMID:
31434613
12.

Generation of two human induced pluripotent stem cell (hiPSC) lines from a long QT syndrome South African founder population.

Mura M, Pisano F, Stefanello M, Ginevrino M, Boni M, Calabrò F, Crotti L, Valente EM, Schwartz PJ, Brink PA, Gnecchi M.

Stem Cell Res. 2019 Aug;39:101510. doi: 10.1016/j.scr.2019.101510. Epub 2019 Jul 24.

13.

Laparoscopic Hysterectomy Route, Resource Use, and Outcomes: Change After Power Morcellation Warning.

Desai VB, Wright JD, Lin H, Gross CP, Sallah YH, Schwartz PE, Xu X.

Obstet Gynecol. 2019 Aug;134(2):227-238. doi: 10.1097/AOG.0000000000003375.

PMID:
31348209
14.

A Community-Wide Collaboration to Reduce Cardiovascular Disease Risk: The Hearts of Sonoma County Initiative.

Cheadle A, Rosaschi M, Burden D, Ferguson M, Greaves B, Houston L, McClendon J, Minkoff J, Jones M, Schwartz P, Nudelman J, Maddux-Gonzalez M.

Prev Chronic Dis. 2019 Jul 11;16:E89. doi: 10.5888/pcd16.180596.

15.

Selenophene-containing heterotriacenes by a C-Se coupling/cyclization reaction.

Schwartz PO, Förtsch S, Vogt A, Mena-Osteritz E, Bäuerle P.

Beilstein J Org Chem. 2019 Jun 24;15:1379-1393. doi: 10.3762/bjoc.15.138. eCollection 2019.

16.

Survival Outcomes Associated With Clinical and Pathological Response Following Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Chemotherapy in Resected Pancreatic Cancer.

Macedo FI, Ryon E, Maithel SK, Lee RM, Kooby DA, Fields RC, Hawkins WG, Williams G, Maduekwe U, Kim HJ, Ahmad SA, Patel SH, Abbott DE, Schwartz P, Weber SM, Scoggins CR, Martin RCG, Dudeja V, Franceschi D, Livingstone AS, Merchant NB.

Ann Surg. 2019 Sep;270(3):400-413. doi: 10.1097/SLA.0000000000003468.

PMID:
31283563
17.

Predictors of Disease-Free and Overall Survival in Retroperitoneal Sarcomas: A Modern 16-Year Multi-Institutional Study from the United States Sarcoma Collaboration (USSC).

Schwartz PB, Vande Walle K, Winslow ER, Ethun CG, Tran TB, Poultsides G, Tseng J, Roggin K, Grignol V, Howard JH, Krasnick BA, Fields RC, Mogal H, Clarke CN, Senehi R, Votanopoulos K, Cardona K, Abbott DE.

Sarcoma. 2019 Jun 2;2019:5395131. doi: 10.1155/2019/5395131. eCollection 2019.

18.

A comparison of linear regression, regularization, and machine learning algorithms to develop Europe-wide spatial models of fine particles and nitrogen dioxide.

Chen J, de Hoogh K, Gulliver J, Hoffmann B, Hertel O, Ketzel M, Bauwelinck M, van Donkelaar A, Hvidtfeldt UA, Katsouyanni K, Janssen NAH, Martin RV, Samoli E, Schwartz PE, Stafoggia M, Bellander T, Strak M, Wolf K, Vienneau D, Vermeulen R, Brunekreef B, Hoek G.

Environ Int. 2019 Sep;130:104934. doi: 10.1016/j.envint.2019.104934. Epub 2019 Jun 20.

19.

Neurosarcoidosis and infliximab therapy monitored by 18FDG PET/CT.

Rivière E, Schwartz P, Machelart I, Greib C, Pellegrin JL, Viallard JF, Lazaro E.

QJM. 2019 Sep 1;112(9):695-697. doi: 10.1093/qjmed/hcz148. No abstract available.

PMID:
31225618
20.

When prescribing drugs, do medical doctors and healthcare professionals realize that their patient has the long QT syndrome?

Schwartz PJ, Woosley RL, Crotti L.

Eur Heart J. 2019 Oct 1;40(37):3118-3120. doi: 10.1093/eurheartj/ehz355. No abstract available.

PMID:
31199477
21.

Calmodulin mutations and life-threatening cardiac arrhythmias: insights from the International Calmodulinopathy Registry.

Crotti L, Spazzolini C, Tester DJ, Ghidoni A, Baruteau AE, Beckmann BM, Behr ER, Bennett JS, Bezzina CR, Bhuiyan ZA, Celiker A, Cerrone M, Dagradi F, De Ferrari GM, Etheridge SP, Fatah M, Garcia-Pavia P, Al-Ghamdi S, Hamilton RM, Al-Hassnan ZN, Horie M, Jimenez-Jaimez J, Kanter RJ, Kaski JP, Kotta MC, Lahrouchi N, Makita N, Norrish G, Odland HH, Ohno S, Papagiannis J, Parati G, Sekarski N, Tveten K, Vatta M, Webster G, Wilde AAM, Wojciak J, George AL, Ackerman MJ, Schwartz PJ.

Eur Heart J. 2019 Sep 14;40(35):2964-2975. doi: 10.1093/eurheartj/ehz311.

PMID:
31170290
22.

Implantable cardioverter-defibrillators in previously undiagnosed patients with catecholaminergic polymorphic ventricular tachycardia resuscitated from sudden cardiac arrest.

van der Werf C, Lieve KV, Bos JM, Lane CM, Denjoy I, Roses-Noguer F, Aiba T, Wada Y, Ingles J, Leren IS, Rudic B, Schwartz PJ, Maltret A, Sacher F, Skinner JR, Krahn AD, Roston TM, Tfelt-Hansen J, Swan H, Robyns T, Ohno S, Roberts JD, van den Berg MP, Kammeraad JA, Probst V, Kannankeril PJ, Blom NA, Behr ER, Borggrefe M, Haugaa KH, Semsarian C, Horie M, Shimizu W, Till JA, Leenhardt A, Ackerman MJ, Wilde AA.

Eur Heart J. 2019 Sep 14;40(35):2953-2961. doi: 10.1093/eurheartj/ehz309.

PMID:
31145795
23.

Persistent Shoulder Pain Due to a Suprascapular Nerve Injury in the Setting of Trauma.

Ohanisian L, Brown N, White SD, Rubay D, Schwartz PM.

Cureus. 2019 Mar 11;11(3):e4224. doi: 10.7759/cureus.4224.

24.

Long QT Syndrome Modelling with Cardiomyocytes Derived from Human-induced Pluripotent Stem Cells.

Sala L, Gnecchi M, Schwartz PJ.

Arrhythm Electrophysiol Rev. 2019 May;8(2):105-110. doi: 10.15420/aer.2019.1.1. Review.

25.

Risk of unexpected uterine Cancer in women undergoing myomectomy: A population-based study.

Desai VB, Wright JD, Gross CP, Lin H, Boscoe FP, Schwartz PE, Xu X.

Eur J Obstet Gynecol Reprod Biol. 2019 Jul;238:188-190. doi: 10.1016/j.ejogrb.2019.03.021. Epub 2019 Mar 20. No abstract available.

PMID:
31103353
26.

Measuring Understanding and Respecting Trust in Biobank Consent.

Kasperbauer TJ, Schwartz PH.

Am J Bioeth. 2019 May;19(5):29-31. doi: 10.1080/15265161.2019.1587034. No abstract available.

PMID:
31090517
27.

Physical Inactivity Is a Risk Factor for Primary Ventricular Fibrillation.

De Ferrari GM, Dusi V, Ruffinazzi M, Gionti V, Cacciavillani L, Noussan P, Zacà V, Sanna T, Crotti L, Schwartz PJ.

J Am Coll Cardiol. 2019 Apr 30;73(16):2117-2118. doi: 10.1016/j.jacc.2019.01.063. No abstract available.

PMID:
31023436
28.

Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation.

Mura M, Lee YK, Pisano F, Ginevrino M, Boni M, Calabrò F, Crotti L, Valente EM, Schwartz PJ, Tse HF, Gnecchi M.

Stem Cell Res. 2019 May;37:101437. doi: 10.1016/j.scr.2019.101437. Epub 2019 Apr 13.

29.

Mexiletine Shortens the QT Interval in Patients With Potassium Channel-Mediated Type 2 Long QT Syndrome.

Bos JM, Crotti L, Rohatgi RK, Castelletti S, Dagradi F, Schwartz PJ, Ackerman MJ.

Circ Arrhythm Electrophysiol. 2019 May;12(5):e007280. doi: 10.1161/CIRCEP.118.007280.

PMID:
31006312
30.

Generation of the human induced pluripotent stem cell (hiPSC) line PSMi004-A from a carrier of the KCNQ1-R594Q mutation.

Mura M, Lee YK, Pisano F, Ginevrino M, Boni M, Calabrò F, Crotti L, Valente EM, Schwartz PJ, Tse HF, Gnecchi M.

Stem Cell Res. 2019 May;37:101431. doi: 10.1016/j.scr.2019.101431. Epub 2019 Mar 27.

31.

Cardiac Sympathetic Denervation in Channelopathies.

Dusi V, De Ferrari GM, Pugliese L, Schwartz PJ.

Front Cardiovasc Med. 2019 Mar 26;6:27. doi: 10.3389/fcvm.2019.00027. eCollection 2019. Review.

32.

Chris Cornell, the Black Hole Sun, and the Seasonality of Suicide.

Schwartz PJ.

Neuropsychobiology. 2019;78(1):38-47. doi: 10.1159/000498868. Epub 2019 Mar 28.

33.

Anticipatory Waivers of Consent for Pediatric Biobanking.

Hartsock JA, Schwartz PH, Waltz AC, Ott MA.

Ethics Hum Res. 2019 Mar;41(2):14-21. doi: 10.1002/eahr.500008.

PMID:
30895753
34.

Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene.

Mura M, Pisano F, Stefanello M, Ginevrino M, Boni M, Calabrò F, Crotti L, Valente EM, Schwartz PJ, Brink PA, Gnecchi M.

Stem Cell Res. 2019 Apr;36:101416. doi: 10.1016/j.scr.2019.101416. Epub 2019 Mar 6.

35.

Prevalence, characteristics, and risk factors of occult uterine cancer in presumed benign hysterectomy.

Desai VB, Wright JD, Gross CP, Lin H, Boscoe FP, Hutchison LM, Schwartz PE, Xu X.

Am J Obstet Gynecol. 2019 Jul;221(1):39.e1-39.e14. doi: 10.1016/j.ajog.2019.02.051. Epub 2019 Mar 7.

PMID:
30853364
36.

Functional imaging of concomitant lingual thyroid and parathyroid adenoma.

Ferriere A, Schwartz P, Haissaguerre M, Hindié E, Tabarin A.

Eur J Nucl Med Mol Imaging. 2019 May;46(5):1201-1202. doi: 10.1007/s00259-019-04283-x. Epub 2019 Feb 20. No abstract available.

PMID:
30788533
37.

Proarrhythmic proclivity of left-stellate ganglion stimulation in a canine model of drug-induced long-QT syndrome type 1.

Ter Bekke RMA, Moers AME, de Jong MMJ, Johnson DM, Schwartz PJ, Vanoli E, Volders PGA.

Int J Cardiol. 2019 Jul 1;286:66-72. doi: 10.1016/j.ijcard.2019.01.098. Epub 2019 Jan 31.

38.

Precision Versus Traditional Medicine-Clinical Questions Trigger Progress in Basic Science.

Schwartz PJ, Sala L.

Circ Res. 2019 Feb 15;124(4):459-461. doi: 10.1161/CIRCRESAHA.119.314629. No abstract available.

PMID:
30763224
39.

From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2.

Schwartz PJ, Gnecchi M, Dagradi F, Castelletti S, Parati G, Spazzolini C, Sala L, Crotti L.

Eur Heart J. 2019 Jun 14;40(23):1832-1836. doi: 10.1093/eurheartj/ehz023.

PMID:
30753398
40.

Sphincter of Oddi Dysfunction After Gastric Bypass: Surgical or Endoscopic Therapy?

Schwartz PB, Easler JJ, Lancaster WP, House MG, Zyromski NJ, Schmidt CM, Nakeeb A, Ceppa EP.

J Surg Res. 2019 Jun;238:41-47. doi: 10.1016/j.jss.2019.01.013. Epub 2019 Feb 6.

PMID:
30738357
41.

International Triadin Knockout Syndrome Registry.

Clemens DJ, Tester DJ, Giudicessi JR, Bos JM, Rohatgi RK, Abrams DJ, Balaji S, Crotti L, Faure J, Napolitano C, Priori SG, Probst V, Rooryck-Thambo C, Roux-Buisson N, Sacher F, Schwartz PJ, Silka MJ, Walsh MA, Ackerman MJ.

Circ Genom Precis Med. 2019 Feb;12(2):e002419. doi: 10.1161/CIRCGEN.118.002419.

PMID:
30649896
42.

PI3K oncogenic mutations mediate resistance to afatinib in HER2/neu overexpressing gynecological cancers.

Bonazzoli E, Cocco E, Lopez S, Bellone S, Zammataro L, Bianchi A, Manzano A, Yadav G, Manara P, Perrone E, Haines K, Espinal M, Dugan K, Menderes G, Altwerger G, Han C, Zeybek B, Litkouhi B, Ratner E, Silasi DA, Huang GS, Azodi M, Schwartz PE, Santin AD.

Gynecol Oncol. 2019 Apr;153(1):158-164. doi: 10.1016/j.ygyno.2019.01.002. Epub 2019 Jan 7.

PMID:
30630630
43.

Developing an Integrative Approach to Female Sexual Desire: The Advances and Drawbacks of Relational and Bodily Experiences Theory.

Velotta N, Schwartz P.

Arch Sex Behav. 2019 Aug;48(6):1715-1718. doi: 10.1007/s10508-018-1352-y. Epub 2019 Jan 3. No abstract available.

PMID:
30607716
44.

Ten-Year Comparison Study of Type 1 and 2 Endometrial Cancers: Risk Factors and Outcomes.

Feinberg J, Albright B, Black J, Lu L, Passarelli R, Gysler S, Whicker M, Altwerger G, Menderes G, Hui P, Santin AD, Azodi M, Silasi DA, Ratner ES, Litkouhi B, Schwartz PE.

Gynecol Obstet Invest. 2019;84(3):290-297. doi: 10.1159/000493132. Epub 2019 Jan 2.

PMID:
30602164
45.

Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors.

Li C, Bonazzoli E, Bellone S, Choi J, Dong W, Menderes G, Altwerger G, Han C, Manzano A, Bianchi A, Pettinella F, Manara P, Lopez S, Yadav G, Riccio F, Zammataro L, Zeybek B, Yang-Hartwich Y, Buza N, Hui P, Wong S, Ravaggi A, Bignotti E, Romani C, Todeschini P, Zanotti L, Zizioli V, Odicino F, Pecorelli S, Ardighieri L, Silasi DA, Litkouhi B, Ratner E, Azodi M, Huang GS, Schwartz PE, Lifton RP, Schlessinger J, Santin AD.

Proc Natl Acad Sci U S A. 2019 Jan 8;116(2):619-624. doi: 10.1073/pnas.1814027116. Epub 2018 Dec 24. Erratum in: Proc Natl Acad Sci U S A. 2019 Mar 19;116(12):5829.

46.

Impact of including quantitative information in a decision aid for colorectal cancer screening: A randomized controlled trial.

Schwartz PH, Imperiale TF, Perkins SM, Schmidt KK, Althouse S, Rawl SM.

Patient Educ Couns. 2019 Apr;102(4):726-734. doi: 10.1016/j.pec.2018.11.010. Epub 2018 Nov 27.

PMID:
30578103
47.

Supporting breast cancer screening decisions for caregivers of older women with dementia: study protocol for a randomized controlled trial.

Fowler NR, Schonberg MA, Sachs GA, Schwartz PH, Gao S, Lane KA, Inger L, Torke AM.

Trials. 2018 Dec 12;19(1):678. doi: 10.1186/s13063-018-3039-z.

48.

Bongani Mayosi, 1967-2018.

Schwartz PJ, Ntsekhe M.

Eur Heart J. 2018 Dec 7;39(46):4051-4061. doi: 10.1093/eurheartj/ehy715. No abstract available.

PMID:
30535016
49.

Alisertib in Combination With Weekly Paclitaxel in Patients With Advanced Breast Cancer or Recurrent Ovarian Cancer: A Randomized Clinical Trial.

Falchook G, Coleman RL, Roszak A, Behbakht K, Matulonis U, Ray-Coquard I, Sawrycki P, Duska LR, Tew W, Ghamande S, Lesoin A, Schwartz PE, Buscema J, Fabbro M, Lortholary A, Goff B, Kurzrock R, Martin LP, Gray HJ, Fu S, Sheldon-Waniga E, Lin HM, Venkatakrishnan K, Zhou X, Leonard EJ, Schilder RJ.

JAMA Oncol. 2019 Jan 1;5(1):e183773. doi: 10.1001/jamaoncol.2018.3773. Epub 2019 Jan 10.

50.

Cardiac sympathetic denervation via a transtracheal approach: It's a long way to Tipperary.

Schwartz PJ, Pugliese L.

Heart Rhythm. 2019 Jan;16(1):125-127. doi: 10.1016/j.hrthm.2018.09.020. Epub 2018 Sep 25. No abstract available.

PMID:
30266688

Supplemental Content

Loading ...
Support Center